Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project BlackRocks IBIT Records 13 Billion Dark Pool Transaction Amid Worsening ETF Outflows Custard Apple Cultivation Hardy Plant Fragile Fruit Poses Export Challenges Venture Capital Turns to Mundane Industries AI and Dealmaking Reshape Accounting and Property Management Blue Silver Ventures Acquires 328K Stake in GameSquare Insider Buying Signals Potential Confidence The One Rule That Can Help Investors Avoid Sophisticated Financial Scams LXP Industrial Trust Q1 2026 Earnings EPS Falls Short of Estimates as Industrial Market Faces Headwinds Commvault Systems Inc CVLT Q1 2026 Earnings EPS Surges Past Expectations as Cloud Growth Momentum Continues WVVI Q1 2024 Earnings Negative EPS Amid Challenging Industry Environment LFMD Q1 2026 Earnings EPS Surprise Lifts Sentiment Despite Disclosed Revenue Uncertainty Norwegian Cruise Line NCLH Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction CAE Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises Belden Inc BDC Faces Selling Pressure Tests Key Support Near 102 Permian Resources Holds Steady After Minor Decline Key Levels in Focus UWM Holdings Stock Edges Higher Key Levels and Market Dynamics at 309 Regency Centers REG Holds Steady Near Support Level as Trading Volume Remains Modest Molson Coors TAP Holds Steady Near Key Support as Trading Volume Remains Muted Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday MRX Q1 2026 Earnings EPS Beats Estimates by 634 as Stock Declines Wellgistics Health Inc WGRX Plunges 22 as Stock Hovers Near Critical Support Level FutureCrest Acquisition Corp FCRS Edges Higher as Stock Consolidates Between Key Levels Alpha Cognition Inc ACOG Edges Lower Amid Selling Pressure Key Support in Focus Darling Ingredients DAR Edges Higher as Support Holds 707 Cayman Holdings JEM Holds Steady at 150 Consolidation Phase Signals Caution DTSTW Warrants Remain Static at Minimal Levels Data Storage Corporation Warrant Trading Flat Pitney Bowes PBI Edges Higher as Stock Holds Key Support Zone Prelude Therapeutics PRLD Extends Gains Support Holds Resistance in Focus